US Stocks
/
Oruka Therapeutics, Inc. Share Price

Oruka Therapeutics, Inc. Share Price

NASDAQ: ORKA | Mid Cap
$97.61
-$0.81 (-0.82%) Last updated on 07 Aug, 2026 | 21:44 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Oruka Therapeutics, Inc. Stock Performance

Open
$99.20
Prev. Close
$98.42
Circuit Range
N/A
Day Range
$97.71 - $99.81
Year Range
$12.90 - $99.81
Volume
8,508
Average Traded
$98.68

Oruka Therapeutics, Inc. Share Price Today

As of 7 August 2026, Oruka Therapeutics, Inc.'s share price is $97.61. The stock opened at $99.20, compared to its previous close of $98.42. During today's trading session, Oruka Therapeutics, Inc.'s share price traded between $97.71 and $99.81, with an average price of $98.76. Over the past 52 weeks, the stock has recorded a high of $99.81 and a low of $12.90. In terms of performance, Oruka Therapeutics, Inc.'s share price has risen by 183.67% over the last six months and is up 559.75% on a year-on-year basis.

Oruka Therapeutics, Inc. Share Price Chart

$97.71$99.81
L
Show Current Price
H

Oruka Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$4.45B
PE Ratio (TTM)
-52.76
Dividend Yield
N/A
EPS (TTM)
$-1.85
Revenue (TTM)
N/A
Return On Equity (TTM)
-22.34%
Profit Margin
N/A
Debt to Equity
0.03
Quarterly Earnings Growth YoY
N/A

Oruka Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2025
RevenueN/AN/AN/A
Net Profit-$2.01M-$2.68M-$30.28M
Net Profit MarginN/AN/AN/A
Income ChangeN/A-33.30%-1030.58%

Oruka Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars202120222025
RevenueN/AN/AN/A
Net Profit-$19.32M-$9.93M-$105.43M
Net Profit MarginN/AN/AN/A
Income ChangeN/A48.63%-962.19%

About Oruka Therapeutics, Inc.

Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 1 trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.

Oruka Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$94.78
$97.71
+1.20%
Jul 2026
$94.76
$96.55
+1.44%
Jun 2026
$57.42
$95.17
+62.75%
May 2026
$68.50
$58.48
-14.79%
Apr 2026
$49.50
$68.63
+39.83%
Mar 2026
$33.70
$49.08
+42.63%
Feb 2026
$34.65
$34.41
+0.56%
Jan 2026
$30.35
$34.22
+12.77%
Dec 2025
$28.90
$30.34
+0.58%
Nov 2025
$27.39
$30.17
+7.18%
Oct 2025
$19.41
$28.15
+45.55%
Sep 2025
$14.85
$19.34
+30.72%

ORKA Share Price FAQs

What is Oruka Therapeutics, Inc. share price today?

chevron-up
Oruka Therapeutics, Inc. share price today is $97.61 as on August 7, 2026 at 9:44 pm IST.

What is the 52 week high and 52 week low of Oruka Therapeutics, Inc. stock?

chevron-up
The 52 week high of Oruka Therapeutics, Inc. stock is $99.81, while the 52 week low is $12.90 as of 7 Aug '26.

What is ORKA's market capitalisation today?

chevron-up
ORKA market capitalisation is $4.45B as of August 7, 2026, at 9:47 pm IST.

What is ORKA's net income for the last quarter?

chevron-up
ORKA's net income for the last quarter is -0.03B USD.

What is the 5 year returns of ORKA?

chevron-up
The 5 year returns of ORKA is 163.24% as on 7 Aug '26.

What is the high & low stock price of ORKA today?

chevron-up
ORKA stock price hit a high of $99.81 and low of $97.71 as of 7 Aug '26.

Can I buy ORKA shares in India?

chevron-up
Yes. You can buy ORKA in India by opening an international trading account.